Biosimilars Are the Billion Dollar Solution We Keep Ignoring
The United States pays more for prescription drugs than any other country. That is not a function of better drugs or better care. It is a result of a deliberately engineered system that protects monopolies, encourages price discrimination, and stifles competition from the very products that could save the system billions: biosimilars. Pharmaceutical companies insist Read More “Biosimilars Are the Billion Dollar Solution We Keep Ignoring”